SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow ... access to advanced DNA and multi-omic ...
BPI France Logo BPI France Logo Arnaud Cutivet - CEO Arnaud Cutivet - CEO Arnaud Cutivet - CEO Arnaud Cutivet - CEO ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval of its in vitro diagnostic (IVD) TruSight™ ...
Attend the virtual, two-day IVD conference where international technical experts and scientists will address key aspects of IVD immunoassay (CLIA, immunoturbidimetry, qualitative and quantitative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback